<qa>  What is the name of the immunotherapy that is eligible for patients who have received human or human- Biologic Therapy: Patients who have received human or humanized monoclonal antibodies will be eligible provided pre-study evaluations demonstrate no significant reactivity with hLL2 IgG i.e., HAHA. 